(Q28542821)
Statements
MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α (English)
0 references
2014
0 references
9
0 references
12
0 references
e115565
0 references
22 December 2014
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference